Your browser doesn't support javascript.
loading
Correction: MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples.
Outeiro-Pinho, Gonçalo; Barros-Silva, Daniela; Aznar, Elena; Sousa, Ana-Isabel; Vieira-Coimbra, Márcia; Oliveira, Jorge; Gonçalves, Céline S; Costa, Bruno M; Junker, Kerstin; Henrique, Rui; Jerónimo, Carmen.
Affiliation
  • Outeiro-Pinho G; Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
  • Barros-Silva D; Master in Molecular Medicine and Oncology, Faculty of Medicine-University of Porto (FMUP), Porto, Portugal.
  • Aznar E; Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
  • Sousa AI; Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
  • Vieira-Coimbra M; Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat de València, CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Camino de Vera s/n, 46022, Valencia, Spain.
  • Oliveira J; Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
  • Gonçalves CS; Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
  • Costa BM; Department of Urology, Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr. António, Bernardino de Almeida, 4200-072, Porto, Portugal.
  • Junker K; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, Braga, Portugal.
  • Henrique R; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, University of Minho, Campus de Gualtar, Braga, Portugal.
  • Jerónimo C; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, Braga, Portugal.
J Exp Clin Cancer Res ; 41(1): 247, 2022 Aug 15.
Article in En | MEDLINE | ID: mdl-35965325
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: J Exp Clin Cancer Res Year: 2022 Document type: Article Affiliation country: Portugal Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: J Exp Clin Cancer Res Year: 2022 Document type: Article Affiliation country: Portugal Country of publication: United kingdom